METHOD FOR TREATING CHRONIC BRONCHOPULMONARY PROCESS AT INBORN DEFECTS OF PULMONARY DEVELOPMENT IN CHILDREN

FIELD: medicine, pulmonology. ^ SUBSTANCE: the innovation includes the impact of haloinhalations from table haloinhaler "Haloneb" at the mode of 0.4-0.6 mg/min in pre-school-aged children and the mode of 0.8-1.2 mg/min in schoolchildren for 10 min. Then for 5 min it is necessary to perform...

Full description

Saved in:
Bibliographic Details
Main Authors VOLKOV I.K, RAZUMOV A.N, KHAN M.A, CHAKHOJAN A.N, BAKANOV M.I, LUKINA O.F
Format Patent
LanguageEnglish
Russian
Published 10.06.2005
Edition7
Subjects
DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
Online AccessGet full text

Cover

More Information
Summary:FIELD: medicine, pulmonology. ^ SUBSTANCE: the innovation includes the impact of haloinhalations from table haloinhaler "Haloneb" at the mode of 0.4-0.6 mg/min in pre-school-aged children and the mode of 0.8-1.2 mg/min in schoolchildren for 10 min. Then for 5 min it is necessary to perform deep slow inhalation through haloinhaler, pause 4-5 sec and expiration into flutter, about 10-12 procedures/course at the background of basic therapy. The method enables to decrease sputum stasis due to improved rheological properties of bronchial secreta and activated function of ciliated epithelium, decreased inflammation, edema and obstruction in bronchi, improved local immune and metabolic processes. ^ EFFECT: higher efficiency of therapy. ^ 2 ex
Bibliography:Application Number: RU20030129038